A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults
Clinical trial NCT04758962 · COMPLETED
Trial details
- NCT number
- NCT04758962
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-15
- Primary completion
- 2021-06-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.